Experimental Drug 'Ulefnersen' Brings Hope for Rare ALS Patients
A novel antisense therapy targeting the FUS gene shows promising results in treating a rare, aggressive form of ALS, with some patients experiencing significant functional recovery and biomarker improvements, leading to ongoing clinical trials.